Neuroprotective gases - Fantasy or reality for clinical use?

Progress in Neurobiology

Volumn 115, Issue C, 2014, Pages 210-245

  Deng, Jiao ^a   Lei, Chong ^a   Chen, Yu ^a   Fang, Zongping ^a   Yang, Qianzi ^a   Zhang, Haopeng ^a   Cai, Min ^a   Shi, Likai ^a   Dong, Hailong ^a   Xiong, Lize ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Clinical translation; Gases; Mechanism; Neuroprotective effect; Research perspectives

Indexed keywords

ARGON; CARBON DIOXIDE; CARBON MONOXIDE; DESFLURANE; ENFLURANE; HALOTHANE; HELIOX; HELIUM; HYDROGEN; HYDROGEN SULFIDE; ION CHANNEL; ISOFLURANE; NEUROPROTECTIVE AGENT; NITRIC OXIDE; NITROUS OXIDE; OXYGEN; SEVOFLURANE; XENON;

ANTIAPOPTOTIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; AUTOPHAGY; BLOOD BRAIN BARRIER; BRAIN HEMORRHAGE; BRAIN HYPOXIA; BRAIN ISCHEMIA; CARBON MONOXIDE INTOXICATION; CELL DEATH; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; COMORBIDITY; DEGENERATIVE DISEASE; DIABETES MELLITUS; DRUG ACTIVITY; DRUG MECHANISM; EVIDENCE BASED PRACTICE; EXCITOTOXICITY; EXTRACELLULAR MATRIX; GAS; HUMAN; HYPERBARIC OXYGEN; HYPERTENSION; HYPOXIC ISCHEMIC ENCEPHALOPATHY; INFLAMMATION; INHALATION ANESTHESIA; INTRACELLULAR SPACE; MITOCHONDRIAL MEMBRANE; NERVE REGENERATION; NERVOUS SYSTEM INJURY; NEUROPHARMACOLOGY; NEUROPROTECTION; NEUROTOXICITY; NEWBORN HYPOXIA; NONHUMAN; OXIDATIVE STRESS; OXYGEN TENSION; OXYGEN THERAPY; PRIORITY JOURNAL; REVIEW; THERAPY EFFECT; TRAUMATIC BRAIN INJURY; TREATMENT OUTCOME; ANIMAL; CLINICAL TRANSLATION; CLINICAL TRIAL (TOPIC); MECHANISM; MEDICAL RECORD; NEUROLOGIC DISEASE; NEUROPROTECTIVE EFFECT; RESEARCH PERSPECTIVES;

CLINICAL TRANSLATION; GASES; MECHANISM; NEUROPROTECTIVE EFFECT; RESEARCH PERSPECTIVES;

ANIMALS; CLINICAL TRIALS AS TOPIC; GASES; HUMANS; MEDICAL RECORDS; NERVOUS SYSTEM DISEASES; NEUROPROTECTIVE AGENTS;

EID: 84907880124     PISSN: 03010082     EISSN: 18735118     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2014.01.001     Document Type: Review

References (423)

1. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N. Engl. J. Med. 1995, 333:1581-1587.
2. Abraini J.H., et al. Potentially neuroprotective and therapeutic properties of nitrous oxide and xenon. Ann. N.Y. Acad. Sci. 2005, 1053:289-300.
3. Acka G., et al. Effect of combined therapy with hyperbaric oxygen and antioxidant on infarct volume after permanent focal cerebral ischemia. Physiol. Res. 2007, 56:369-373.
4. Adamczyk S., et al. Sevoflurane pre- and post-conditioning protect the brain via the mitochondrial K ATP channel. Br. J. Anaesth. 2010, 104:191-200.
5. Akca O. Optimizing the intraoperative management of carbon dioxide concentration. Curr. Opin. Anaesthesiol. 2006, 19:19-25.
6. Alex J., et al. Pretreatment with hyperbaric oxygen and its effect on neuropsychometric dysfunction and systemic inflammatory response after cardiopulmonary bypass: a prospective randomized double-blind trial. J. Thorac. Cardiovasc. Surg. 2005, 130:1623-1630.
7. Altay O., et al. Isoflurane on brain inflammation. Neurobiol. Dis. 2013, 62C:365-371.
8. Annane D., et al. Hyperbaric oxygen therapy for acute domestic carbon monoxide poisoning: two randomized controlled trials. Intensive Care Med. 2011, 37:486-492.
9. Atochin D.N., et al. Neutrophil sequestration and the effect of hyperbaric oxygen in a rat model of temporary middle cerebral artery occlusion. Undersea Hyperb. Med. 2000, 27:185-190.
10. Aviles-Olmos I., et al. Parkinson's disease, insulin resistance and novel agents of neuroprotection. Brain 2013, 136:374-384.
11. Aydin A., et al. Effect of hyperbaric oxygen therapy on nerve regeneration in early diabetes. Microsurgery 2004, 24:255-261.
12. Badr A.E., et al. Dual effect of HBO on cerebral infarction in MCAO rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2001, 280:R766-R770.
13. Badr A.E., et al. Effect of hyperbaric oxygen on striatal metabolites: a microdialysis study in awake freely moving rats after MCA occlusion. Brain Res. 2001, 916:85-90.
14. Baldauf K., et al. Detrimental effects of halothane narcosis on damage after endothelin-1-induced MCAO. J. Neurosci. Methods 2007, 162:14-18.
15. Ballanyi K. Protective role of neuronal KATP channels in brain hypoxia. J. Exp. Biol. 2004, 207:3201-3212.
16. Bantel C., et al. Neuronal preconditioning by inhalational anesthetics: evidence for the role of plasmalemmal adenosine triphosphate-sensitive potassium channels. Anesthesiology 2009, 110:986-995.
17. Bantel C., et al. Noble gas xenon is a novel adenosine triphosphate-sensitive potassium channel opener. Anesthesiology 2010, 112:623-630.
18. Barkoudah E., et al. The permissive role of endothelial NO in CO-induced cerebrovascular dilation. Am. J. Physiol. Heart Circ. Physiol. 2004, 287:H1459-H1460.
19. 2O. Anesthesiology 1988, 69:192-198.
20. Bedirli N., et al. Sevoflurane and isoflurane preconditioning provides neuroprotection by inhibition of apoptosis-related mRNA expression in a rat model of focal cerebral ischemia. J. Neurosurg. Anesthesiol. 2012, 24:336-344.
21. Benarroch E.E. Nitric oxide: a pleiotropic signal in the nervous system. Neurology 2011, 77:1568-1576.
22. Benavides R., et al. Expansion of gas bubbles by nitrous oxide and xenon. Anesthesiology 2006, 104:299-302.
23. Bennett M.H., et al. Hyperbaric oxygen therapy for the adjunctive treatment of traumatic brain injury. Cochrane Database Syst. Rev. 2012, 12:CD004609.
24. Beynon C., et al. Delayed hyperbaric oxygenation is more effective than early prolonged normobaric hyperoxia in experimental focal cerebral ischemia. Neurosci. Lett. 2007, 425:141-145.
25. 2+-dependent survival signaling in cortical neurons and modulates MAP kinases, apoptosis proteins and transcription factors during hypoxia. Anesth. Analg. 2006, 103:419-429.
26. Bickler P.E., et al. gamma-Aminobutyric acid-A receptors contribute to isoflurane neuroprotection in organotypic hippocampal cultures. Anesth. Analg. 2003, 97:564-571.
27. Biedler A., et al. Cognitive impairment in the early postoperative period after remifentanil-propofol and sevoflurane-fentanyl anesthesia. Anaesthesist 2000, 49:286-290.
28. Bigdeli M.R. Preconditioning with prolonged normobaric hyperoxia induces ischemic tolerance partly by upregulation of antioxidant enzymes in rat brain tissue. Brain Res. 2009, 1260:47-54.
29. Bigdeli M.R., et al. Time course of neuroprotection induced by normobaric hyperoxia in focal cerebral ischemia. Neurol. Res. 2012, 34:439-446.
30. Bigdeli M.R., et al. Prolonged and intermittent normobaric hyperoxia induce different degrees of ischemic tolerance in rat brain tissue. Brain Res. 2007, 1152:228-233.
31. Bigdeli M.R., Khoshbaten A. In vivo preconditioning with normobaric hyperoxia induces ischemic tolerance partly by triggering tumor necrosis factor-alpha converting enzyme/tumor necrosis factor-alpha/nuclear factor-kappaB. Neuroscience 2008, 153:671-678.
32. Bigdeli M.R., et al. Preconditioning with sublethal ischemia or intermittent normobaric hyperoxia up-regulates glutamate transporters and tumor necrosis factor-alpha converting enzyme in the rat brain. J. Stroke Cerebrovasc. Dis. 2009, 18:336-342.
33. Bilotta F., et al. Early postoperative cognitive recovery and gas exchange patterns after balanced anesthesia with sevoflurane or desflurane in overweight and obese patients undergoing craniotomy: a prospective randomized trial. J. Neurosurg. Anesthesiol. 2009, 21:207-213.
34. 2+/calmodulin-dependent protein kinase in a canine cardiac arrest model. Anesthesiology 2000, 93:1285-1293.
35. Bleilevens C., et al. Effect of anesthesia and cerebral blood flow on neuronal injury in a rat middle cerebral artery occlusion (MCAO) model. Exp. Brain Res. 2013, 224:155-164.
36. Boop W.C., Knight R. Enflurane anesthesia and changes of intracranial pressure. J. Neurosurg. 1978, 48:228-231.
37. Brosnan H., Bickler P.E. Xenon neurotoxicity in rat hippocampal slice cultures is similar to isoflurane and sevoflurane. Anesthesiology 2013, 119:335-344.
38. 2 on injury volume and CSF beta-endorphin levels in focal cerebral ischemia. Mol. Chem. Neuropathol. 1997, 31:29-42.
39. Brucken A., et al. Argon reduces neurohistopathological damage and preserves functional recovery after cardiac arrest in rats. Br. J. Anaesth. 2013.
40. Brune B., Ullrich V. Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase. Mol. Pharmacol. 1987, 32:497-504.
41. Brvar M., et al. S100B protein in conscious carbon monoxide-poisoned rats treated with normobaric or hyperbaric oxygen. Crit. Care Med. 2006, 34:2228-2230.
42. Brvar M., et al. The time-dependent protective effect of hyperbaric oxygen on neuronal cell apoptosis in carbon monoxide poisoning. Inhal. Toxicol. 2010, 22:1026-1031.
43. Buckley N.A., et al. Hyperbaric oxygen for carbon monoxide poisoning. Cochrane Database Syst. Rev. 2011, CD002041.
44. Bunc M., et al. Immediate oxygen therapy prevents brain cell injury in carbon monoxide poisoned rats without loss of consciousness. Toxicology 2006, 225:138-141.
45. Buras J.A., et al. Hyperbaric oxygen downregulates ICAM-1 expression induced by hypoxia and hypoglycemia: the role of NOS. Am. J. Physiol. Cell Physiol. 2000, 278:C292-C300.
46. Cai J., et al. Neuroprotective effects of hydrogen saline in neonatal hypoxia-ischemia rat model. Brain Res. 2009, 1256:129-137.
47. Cai J., et al. Hydrogen therapy reduces apoptosis in neonatal hypoxia-ischemia rat model. Neurosci. Lett. 2008, 441:167-172.
48. Calvert J.W., et al. Hyperbaric oxygen and cerebral physiology. Neurol. Res. 2007, 29:132-141.
49. Canas P.T., et al. Sevoflurane protects rat mixed cerebrocortical neuronal-glial cell cultures against transient oxygen-glucose deprivation: involvement of glutamate uptake and reactive oxygen species. Anesthesiology 2006, 105:990-998.
50. Cao W., et al. Roles of aldosterone and oxytocin in abnormalities caused by sevoflurane anesthesia in neonatal rats. Anesthesiology 2012, 117:791-800.
51. Carla V., Moroni F. General anaesthetics inhibit the responses induced by glutamate receptor agonists in the mouse cortex. Neurosci. Lett. 1992, 146:21-24.
52. Cattano D., et al. Xenon exposure in the neonatal rat brain: effects on genes that regulate apoptosis. Minerva Anestesiol. 2011, 77:571-578.
53. Cattano D., et al. Potential of xenon to induce or to protect against neuroapoptosis in the developing mouse brain. Can. J. Anaesth. 2008, 55:429-436.
54. 2) for acute carbon monoxide poisoning. Bratisl. Lek. Listy 2009, 110:716-718.
55. Charriaut-Marlangue C., et al. Inhaled nitric oxide reduces brain damage by collateral recruitment in a neonatal stroke model. Stroke 2012, 43:3078-3084.
56. Chateau-Degat M.L., Belley R. Hyperbaric oxygen therapy decreases blood pressure in patients with chronic wounds. Undersea Hyperbaric Med.: J. Undersea Hyperbaric Med. Soc. 2012, 39:881-889.
57. Chen C.H., et al. Hydrogen gas reduced acute hyperglycemia-enhanced hemorrhagic transformation in a focal ischemia rat model. Neuroscience 2010, 169:402-414.
58. Chen J., Chen Y.H. Effects of hyperbaric oxygen on synaptic ultrastructure and synaptophysin expression in hippocampus of neonatal rats with hypoxic-ischemic brain damage. Zhonghua Er Ke Za Zhi 2010, 48:199-203.
59. Chen Q., et al. Functional inhibition of rat polymorphonuclear leukocyte B2 integrins by hyperbaric oxygen is associated with impaired cGMP synthesis. J. Pharmacol. Exp. Ther. 1996, 276:929-933.
60. Chen Q., et al. Effect of sevoflurane postconditioning on spinal cord ischemia reperfusion injury via the release of oxygen free radicals in rabbits. Zhonghua Yi Xue Za Zhi 2008, 88:1916-1920.
61. Cheng O., et al. Cyclooxygenase-2 mediates hyperbaric oxygen preconditioning in the rat model of transient global cerebral ischemia. Stroke 2011, 42:484-490.
62. Chlopicki S., et al. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase. Cardiovasc. Res. 2006, 71:393-401.
63. Chora A.A., et al. Heme oxygenase-1 and carbon monoxide suppress autoimmune neuroinflammation. J. Clin. Invest. 2007, 117:438-447.
64. Clarkson A.N. Anesthetic-mediated protection/preconditioning during cerebral ischemia. Life Sci. 2007, 80:1157-1175.
65. 2 modulates intracellular pH, intracellular oxidant generation, and interleukin-8 secretion in human neutrophils. J. Leukoc. Biol. 2002, 71:603-610.
66. Coburn M., et al. Emergence and early cognitive function in the elderly after xenon or desflurane anaesthesia: a double-blinded randomized controlled trial. Br. J. Anaesth. 2007, 98:756-762.
67. Coburn M., et al. The neuroprotective effects of xenon and helium in an in vitro model of traumatic brain injury. Crit. Care Med. 2008, 36:588-595.
68. Coburn R.F., et al. Endogenous carbon monoxide production in man. J. Clin. Invest. 1963, 42:1172-1178.
69. Codaccioni J.L., et al. Sevoflurane preconditioning against focal cerebral ischemia: inhibition of apoptosis in the face of transient improvement of neurological outcome. Anesthesiology 2009, 110:1271-1278.
70. Cope A., et al. Retinal artery occlusion: visual outcome after treatment with hyperbaric oxygen. Diving Hyperbaric Med.: J. S. Pacific Underwater Med. Soc. 2011, 41:135-138.
71. Cullen S.C., Gross E.G. The anesthetic properties of xenon in animals and human beings, with additional observations on krypton. Science (New York, NY) 1951, 113:580-582.
72. Dabrowski W., et al. Volatile anesthetics reduce biochemical markers of brain injury and brain magnesium disorders in patients undergoing coronary artery bypass graft surgery. J. Cardiothorac. Vasc. Anesth. 2012, 26:395-402.
73. Dallas M.L., et al. Carbon monoxide protects against oxidant-induced apoptosis via inhibition of Kv2.1. FASEB J. 2011, 25:1519-1530.
74. David H.N., et al. Post-ischemic helium provides neuroprotection in rats subjected to middle cerebral artery occlusion-induced ischemia by producing hypothermia. J. Cereb. Blood Flow Metab. 2009, 29:1159-1165.
75. David H.N., et al. Ex vivo and in vivo neuroprotection induced by argon when given after an excitotoxic or ischemic insult. PLoS ONE 2012, 7:e30934.
76. David H.N., et al. Reduction of ischemic brain damage by nitrous oxide and xenon. J. Cereb. Blood Flow Metab. 2003, 23:1168-1173.
77. De La Monte S.M. Metabolic derangements mediate cognitive impairment and Alzheimer's disease: role of peripheral insulin-resistance diseases. Panminerva Med. 2012, 54:171-178.
78. de Rooij N.K., et al. Delayed cerebral ischemia after subarachnoid hemorrhage: a systematic review of clinical, laboratory, and radiological predictors. Stroke 2013, 44:43-54.
79. Delphin E., et al. Sevoflurane provides earlier tracheal extubation and assessment of cognitive recovery than isoflurane in patients undergoing off-pump coronary artery bypass surgery. J. Cardiothorac. Vasc. Anesth. 2007, 21:690-695.
80. Dickinson R., Franks N.P. Bench-to-bedside review: molecular pharmacology and clinical use of inert gases in anesthesia and neuroprotection. Crit. Care 2010, 14:229.
81. Dickinson R., et al. Competitive inhibition at the glycine site of the N-methyl-d-aspartate receptor by the anesthetics xenon and isoflurane. Anesthesiology 2007, 107:756-767.
82. Ding Q., et al. Sevoflurane preconditioning induces rapid ischemic tolerance against spinal cord ischemia/reperfusion through activation of extracellular signal-regulated kinase in rabbits. Anesth. Analg. 2009, 109:1263-1272.
83. Dingley J., et al. Xenon provides short-term neuroprotection in neonatal rats when administered after hypoxia-ischemia. Stroke 2006, 37:501-506.
84. Diringer M.N., et al. Effect of hyperoxia on cerebral metabolic rate for oxygen measured using positron emission tomography in patients with acute severe head injury. J. Neurosurg. 2007, 106:526-529.
85. Dirnagl U., et al. Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use. Lancet Neurol. 2009, 8:398-412.
86. Dirnagl U., et al. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 1999, 22:391-397.
87. Doehner W., et al. Overweight and obesity are associated with improved survival, functional outcome, and stroke recurrence after acute stroke or transient ischaemic attack: observations from the TEMPiS trial. Eur. Heart J. 2013, 34:268-277.
88. Dole M., et al. Hyperbaric hydrogen therapy: a possible treatment for cancer. Science 1975, 190:152-154.
89. Dong H., et al. Preconditioning with hyperbaric oxygen and hyperoxia induces tolerance against spinal cord ischemia in rabbits. Anesthesiology 2002, 96:907-912.
90. Dworschak M. Pharmacologic neuroprotection - is xenon the light at the end of the tunnel?. Crit. Care Med. 2008, 36:2477-2479.
91. Eberspacher E., et al. Effects of sevoflurane on cognitive deficit, motor function, and histopathology after cerebral ischemia in rats. Acta Anaesthesiol. Scand. 2009, 53:774-782.
92. Efrati S., et al. Hyperbaric oxygen induces late neuroplasticity in post stroke patients - randomized, prospective trial. PLoS ONE 2013, 8:e53716.
93. Elsersy H., et al. Effects of isoflurane versus fentanyl-nitrous oxide anesthesia on long-term outcome from severe forebrain ischemia in the rat. Anesthesiology 2004, 100:1160-1166.
94. Engelhard K., et al. The effect of sevoflurane and propofol on cerebral neurotransmitter concentrations during cerebral ischemia in rats. Anesth. Analg. 2003, 97:1155-1161.
95. Engelhard K., et al. Desflurane and isoflurane improve neurological outcome after incomplete cerebral ischaemia in rats. Br. J. Anaesth. 1999, 83:415-421.
96. Engelhard K., et al. Sevoflurane affects neurogenesis after forebrain ischemia in rats. Anesth. Analg. 2007, 104:898-903.
97. Erdem A.F., et al. Effects of sevoflurane and desflurane in CA1 after incomplete cerebral ischemia in rats. Saudi Med. J. 2005, 26:1424-1428.
98. Ergul A., et al. Cerebrovascular complications of diabetes: focus on stroke. Endocr. Metab. Immune Disord. Drug Targets 2012, 12:148-158.
99. Fahlenkamp A.V., et al. Xenon enhances LPS-induced IL-1beta expression in microglia via the extracellular signal-regulated kinase 1/2 pathway. J. Mol. Neurosci. 2011, 45:48-59.
100. Fahlenkamp A.V., et al. The noble gas argon modifies extracellular signal-regulated kinase 1/2 signaling in neurons and glial cells. Eur. J. Pharmacol. 2012, 674:104-111.
101. Fang F., et al. Sevoflurane exposure in 7-day-old rats affects neurogenesis, neurodegeneration and neurocognitive function. Neurosci. Bull. 2012, 28:499-508.
102. Feng X., et al. Single sevoflurane exposure decreases neuronal nitric oxide synthase levels in the hippocampus of developing rats. Br. J. Anaesth. 2012, 109:225-233.
103. Fonarow G.C., et al. Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes. Circulation 2011, 123:750-758.
104. Franks N.P., et al. How does xenon produce anaesthesia?. Nature 1998, 396:324.
105. Freiberger J.J., et al. A comparison of hyperbaric oxygen versus hypoxic cerebral preconditioning in neonatal rats. Brain Res. 2006, 1075:213-222.
106. Fries M., et al. Xenon reduces neurohistopathological damage and improves the early neurological deficit after cardiac arrest in pigs. Crit. Care Med. 2008, 36:2420-2426.
107. Frost R.B., et al. Prevalence of traumatic brain injury in the general adult population: a meta-analysis. Neuroepidemiology 2013, 40:154-159.
108. Fu Y., et al. Molecular hydrogen is protective against 6-hydroxydopamine-induced nigrostriatal degeneration in a rat model of Parkinson's disease. Neurosci. Lett. 2009, 453:81-85.
109. Fujiwara N., et al. Combination therapy with normobaric oxygen (NBO) plus thrombolysis in experimental ischemic stroke. BMC Neurosci. 2009, 10:79.
110. Ge P., et al. Inhalation of hydrogen gas attenuates cognitive impairment in transient cerebral ischemia via inhibition of oxidative stress. Neurol. Res. 2012, 34:187-194.
111. Goto T., et al. The blood-gas partition coefficient of xenon may be lower than generally accepted. Br. J. Anaesth. 1998, 80:255-256.
112. Gotts J.E., et al. Focal brain injury, FGF-2 and the adverse effects of excessive motor demand on cortical and nigral degeneration: marked protection by delayed intermittent exposure to halothane. J. Neurotrauma 2000, 17:1067-1077.
113. Grabb M.C., Choi D.W. Ischemic tolerance in murine cortical cell culture: critical role for NMDA receptors. J. Neurosci.: Off. J. Soc. Neurosci. 1999, 19:1657-1662.
114. 2+ and mitogen-activated protein kinases. Anesthesiology 2005, 102:606-615.
115. Grocott H.P., et al. The influence of xenon, nitrous oxide and nitrogen on gas bubble expansion during cardiopulmonary bypass. Eur. J. Anaesthesiol. 2005, 22:353-358.
116. + channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane. Mol. Pharmacol. 2004, 65:443-452.
117. Gu N., et al. Hyperbaric oxygen therapy attenuates neuropathic hyperalgesia in rats and idiopathic trigeminal neuralgia in patients. Eur. J. Pain 2012, 16:1094-1105.
118. Haelewyn B., et al. Neuroprotection by nitrous oxide: facts and evidence. Crit. Care Med. 2008, 36:2651-2659.
119. Haelewyn B., et al. Desflurane affords greater protection than halothane against focal cerebral ischaemia in the rat. Br. J. Anaesth. 2003, 91:390-396.
120. Haji S.A., Frenkel R.E. Hyperbaric oxygen therapy for the treatment of radiation-induced macular ischemia. Clin. Ophthalmol. 2010, 4:433-436.
121. Han R.Q., et al. The effect of isoflurane induced hypotension on intraoperative cerebral vasospasm in intracranial aneurysm surgery. Zhonghua Yi Xue Za Zhi 2004, 84:286-289.
122. Harch P.G., et al. A phase I study of low-pressure hyperbaric oxygen therapy for blast-induced post-concussion syndrome and post-traumatic stress disorder. J. Neurotrauma 2012, 29:168-185.
123. Haseneder R., et al. Xenon attenuates excitatory synaptic transmission in the rodent prefrontal cortex and spinal cord dorsal horn. Anesthesiology 2009, 111:1297-1307.
124. Heinen A., et al. Helium-induced preconditioning in young and old rat heart: impact of mitochondrial Ca(2+)-sensitive potassium channel activation. Anesthesiology 2008, 109:830-836.
125. Hendrich K.S., et al. Cerebral perfusion during anesthesia with fentanyl, isoflurane, or pentobarbital in normal rats studied by arterial spin-labeled MRI. Magn. Reson. Med. 2001, 46:202-206.
126. Henninger N., et al. Normobaric hyperoxia delays perfusion/diffusion mismatch evolution, reduces infarct volume, and differentially affects neuronal cell death pathways after suture middle cerebral artery occlusion in rats. J. Cereb. Blood Flow Metab. 2007, 27:1632-1642.
127. Hertle D., et al. Influence of isoflurane on neuronal death and outcome in a rat model of traumatic brain injury. Acta Neurochir. Suppl. 2012, 114:383-386.
128. + channel involved in neuroprotection and general anesthesia. EMBO J. 2004, 23:2684-2695.
129. Hobbs C., et al. Xenon and hypothermia combine additively, offering long-term functional and histopathologic neuroprotection after neonatal hypoxia/ischemia. Stroke 2008, 39:1307-1313.
130. Hocker J., et al. Postoperative neurocognitive dysfunction in elderly patients after xenon versus propofol anesthesia for major noncardiac surgery: a double-blinded randomized controlled pilot study. Anesthesiology 2009, 110:1068-1076.
131. Hoffman W.E., et al. Desflurane increases brain tissue oxygenation and pH. Acta Anaesthesiol. Scand. 1997, 41:1162-1166.
132. Hoffman W.E., et al. Thiopental and desflurane treatment for brain protection. Neurosurgery 1998, 43:1050-1053.
133. Hoffman W.E., et al. Comparison of the effect of etomidate and desflurane on brain tissue gases and pH during prolonged middle cerebral artery occlusion. Anesthesiology 1998, 88:1188-1194.
134. Holmstrom A., Akeson J. Desflurane increases intracranial pressure more and sevoflurane less than isoflurane in pigs subjected to intracranial hypertension. J. Neurosurg. Anesthesiol. 2004, 16:136-143.
135. Hou L., et al. 100% oxygen inhalation protects against zymosan-induced sterile sepsis in mice: the roles of inflammatory cytokines and antioxidant enzymes. Shock 2009, 32:451-461.
136. Hu L.F., et al. Hydrogen sulfide inhibits rotenone-induced apoptosis via preservation of mitochondrial function. Mol. Pharmacol. 2009, 75:27-34.
137. Hu L.F., et al. Hydrogen sulfide attenuates lipopolysaccharide-induced inflammation by inhibition of p38 mitogen-activated protein kinase in microglia. J. Neurochem. 2007, 100:1121-1128.
138. Hu Q., et al. Isoflurane enhanced hemorrhagic transformation by impairing antioxidant enzymes in hyperglycemic rats with middle cerebral artery occlusion. Stroke 2011, 42:1750-1756.
139. 2 following TBI at high altitude by hyperbaric oxygen pre-conditioning. Neurol. Res. 2010, 32:173-178.
140. Huang L., Obenaus A. Hyperbaric oxygen therapy for traumatic brain injury. Med. Gas Res. 2011, 1:21.
141. Huang Y., et al. Beneficial effects of hydrogen gas against spinal cord ischemia-reperfusion injury in rabbits. Brain Res. 2011, 1378:125-136.
142. Hugyecz M., et al. Hydrogen supplemented air inhalation reduces changes of prooxidant enzyme and gap junction protein levels after transient global cerebral ischemia in the rat hippocampus. Brain Res. 2011, 1404:31-38.
143. Huhn R., et al. Helium-induced late preconditioning in the rat heart in vivo. Br. J. Anaesth. 2009, 102:614-619.
144. Huhn R., et al. Helium-induced early preconditioning and postconditioning are abolished in obese Zucker rats in vivo. J. Pharmacol. Exp. Ther. 2009, 329:600-607.
145. Iadecola C. Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci. 1997, 20:132-139.
146. Ikonomidou C., et al. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 1999, 283:70-74.
147. Inoue S., et al. Combination of isoflurane and caspase inhibition reduces cerebral injury in rats subjected to focal cerebral ischemia. Anesthesiology 2004, 101:75-81.
148. Istaphanous G.K., et al. Comparison of the neuroapoptotic properties of equipotent anesthetic concentrations of desflurane, isoflurane, or sevoflurane in neonatal mice. Anesthesiology 2011, 114:578-587.
149. + channels. Circ. Res. 2002, 91:610-617.
150. Jawad N., et al. Neuroprotection (and lack of neuroprotection) afforded by a series of noble gases in an in vitro model of neuronal injury. Neurosci. Lett. 2009, 460:232-236.
151. Jeon Y.T., et al. A combination of sevoflurane postconditioning and albumin increases Bcl-2 expression after transient global cerebral ischemia compared with either sevoflurane postconditioning or albumin alone. J. Neurosurg. Anesthesiol. 2013, 25:43-50.
152. Ji X., et al. Beneficial effects of hydrogen gas in a rat model of traumatic brain injury via reducing oxidative stress. Brain Res. 2010, 1354:196-205.
153. Jiang J., Tyssebotn I. Normobaric and hyperbaric oxygen treatment of acute carbon monoxide poisoning in rats. Undersea Hyperb. Med. 1997, 24:107-116.
154. Jordan B.D., Wright E.L. Xenon as an anesthetic agent. AANA J. 2010, 78:387-392.
155. Joyce J.A. Xenon: anesthesia for the 21st century. AANA J. 2000, 68:259-264.
156. Jungwirth B., et al. Xenon impairs neurocognitive and histologic outcome after cardiopulmonary bypass combined with cerebral air embolism in rats. Anesthesiology 2006, 104:770-776.
157. Kabil O., Banerjee R. Redox biochemistry of hydrogen sulfide. J. Biol. Chem. 2010, 285:21903-21910.
158. Kanbak M., et al. The effects of isoflurane, sevoflurane, and desflurane anesthesia on neurocognitive outcome after cardiac surgery: a pilot study. Heart Surg. Forum 2007, 10:E36-E41.
159. Kanbak M., et al. Propofol offers no advantage over isoflurane anesthesia for cerebral protection during cardiopulmonary bypass: a preliminary study of S-100beta protein levels. Can. J. Anaesth. 2004, 51:712-717.
160. Kanno T., Nonomura K. Hyperbaric oxygen therapy to determine the surgical indication of moderate hypertensive intracerebral hemorrhage. Minimal. Invasive Neurosurg.: MIN 1996, 39:56-59.
161. Kanu A., et al. Cyclooxygenase products stimulate carbon monoxide production by piglet cerebral microvessels. Exp. Biol. Med. 2006, 231:181-185.
162. + channels in cerebral arteriolar responses to glutamate and hypoxia in newborn pigs. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H3193-H3200.
163. Kanu A., Leffler C.W. Roles of glia limitans astrocytes and carbon monoxide in adenosine diphosphate-induced pial arteriolar dilation in newborn pigs. Stroke 2009, 40:930-935.
164. Kanu A., Leffler C.W. Arachidonic acid- and prostaglandin E2-induced cerebral vasodilation is mediated by carbon monoxide, independent of reactive oxygen species in piglets. Am. J. Physiol. Heart Circ. Physiol. 2011, 301:H2482-H2490.
165. Kanu A., et al. Carbon monoxide contributes to hypotension-induced cerebrovascular vasodilation in piglets. Am. J. Physiol. Heart Circ. Physiol. 2006, 291:H2409-H2410.
166. Kapinya K.J., et al. Tolerance against ischemic neuronal injury can be induced by volatile anesthetics and is inducible NO synthase dependent. Stroke 2002, 33:1889-1898.
167. Katsumata T., et al. Correlation between insulin resistance and white matter lesions among non-diabetic patients with ischemic stroke. Neurol. Res. 2010, 32:743-747.
168. Kawaguchi M., et al. Effect of isoflurane on neuronal apoptosis in rats subjected to focal cerebral ischemia. Anesth. Analg. 2004, 98:798-805.
169. Kehl F., et al. Sevoflurane-induced preconditioning of rat brain in vitro and the role of KATP channels. Brain Res. 2004, 1021:76-81.
170. Keynes R.G., Garthwaite J. Nitric oxide and its role in ischaemic brain injury. Curr. Mol. Med. 2004, 4:179-191.
171. Khaspekov L., et al. Sublethal in vitro glucose-oxygen deprivation protects cultured hippocampal neurons against a subsequent severe insult. Neuroreport 1998, 9:1273-1276.
172. Kida K., et al. Inhaled hydrogen sulfide prevents neurodegeneration and movement disorder in a mouse model of Parkinson's disease. Antioxid. Redox Signal. 2011, 15:343-352.
173. Kim H.Y., et al. Normobaric hyperoxia extends the reperfusion window in focal cerebral ischemia. Ann. Neurol. 2005, 57:571-575.
174. Kimbro J.R., et al. Isoflurane and pentobarbital reduce AMPA toxicity in vivo in the rat cerebral cortex. Anesthesiology 2000, 92:806-812.
175. Kimura H. Hydrogen sulfide induces cyclic AMP and modulates the NMDA receptor. Biochem. Biophys. Res. Commun. 2000, 267:129-133.
176. Kimura Y., Kimura H. Hydrogen sulfide protects neurons from oxidative stress. FASEB J. 2004, 18:1165-1167.
177. Kitaguchi K., et al. Effects of sevoflurane on cerebral circulation and metabolism in patients with ischemic cerebrovascular disease. Anesthesiology 1993, 79:704-709.
178. Kitano H., et al. Gender-specific response to isoflurane preconditioning in focal cerebral ischemia. J. Cereb. Blood Flow Metab. 2007, 27:1377-1386.
179. Kohzuki M., et al. Long-term neuroprotective effects of carbon dioxide on neonatal rat hypoxic-ischemic brain injury: an experimental study of skilled motor tasks. Am. J. Obstet. Gynecol. 2006, 195:240-245.
180. Kwon J.Y., et al. Effects of pentobarbital and isoflurane on conditioned learning after transient global cerebral ischemia in rabbits. Anesthesiology 2000, 92:171-177.
181. Lafay V., et al. ECG changes during the experimental human dive HYDRA 10 (71atm/7,200kPa). Undersea Hyperb. Med. 1995, 22:51-60.
182. Lai T.W., et al. Stroke intervention pathways: NMDA receptors and beyond. Trends Mol. Med. 2011, 17:266-275.
183. Larsen B., et al. Recovery of cognitive function after remifentanil-propofol anesthesia: a comparison with desflurane and sevoflurane anesthesia. Anesth. Analg. 2000, 90:168-174.
184. Lee H.M., et al. Sevoflurane-induced post-conditioning has no beneficial effects on neuroprotection after incomplete cerebral ischemia in rats. Acta Anaesthesiol. Scand. 2010, 54:328-336.
185. Lee J.J., et al. Postconditioning with isoflurane reduced ischemia-induced brain injury in rats. Anesthesiology 2008, 108:1055-1062.
186. Lee M., et al. Astrocytes produce the antiinflammatory and neuroprotective agent hydrogen sulfide. Neurobiol. Aging 2009, 30:1523-1534.
187. Leffler C.W., et al. Carbon monoxide and hydrogen sulfide: gaseous messengers in cerebrovascular circulation. J. Appl. Physiol. 2006, 100:1065-1076.
188. Li H., et al. Isoflurane postconditioning reduces ischemia-induced nuclear factor-kappaB activation and interleukin 1beta production to provide neuroprotection in rats and mice. Neurobiol. Dis. 2013, 54:216-224.
189. Li J., et al. Hyperbaric oxygen preconditioning induces tolerance against brain ischemia-reperfusion injury by upregulation of antioxidant enzymes in rats. Brain Res. 2008, 1210:223-229.
190. Li J., et al. Hydrogen-rich saline improves memory function in a rat model of amyloid-beta-induced Alzheimer's disease by reduction of oxidative stress. Brain Res. 2010, 1328:152-161.
191. Li J.S., et al. Hyperbaric oxygen preconditioning reduces ischemia-reperfusion injury by inhibition of apoptosis via mitochondrial pathway in rat brain. Neuroscience 2009, 159:1309-1315.
192. Li J.T., et al. Anesthetic isoflurane posttreatment attenuates experimental lung injury by inhibiting inflammation and apoptosis. Mediators Inflamm. 2013, 108928.
193. Li L., et al. Hydrogen sulphide - a novel mediator of inflammation?. Curr. Opin. Pharmacol. 2006, 6:125-129.
194. Li L., et al. Actions and interactions of nitric oxide, carbon monoxide and hydrogen sulphide in the cardiovascular system and in inflammation - a tale of three gases!. Pharmacol. Ther. 2009, 123:386-400.
195. Li L., et al. Isoflurane preconditioning increases B-cell lymphoma-2 expression and reduces cytochrome c release from the mitochondria in the ischemic penumbra of rat brain. Eur. J. Pharmacol. 2008, 586:106-113.
196. Li L., Zuo Z. Isoflurane preconditioning improves short-term and long-term neurological outcome after focal brain ischemia in adult rats. Neuroscience 2009, 164:497-506.
197. Li M.H., et al. Calcium-permeable ion channels involved in glutamate receptor-independent ischemic brain injury. Acta Pharmacol. Sin. 2011, 32:734-740.
198. Li W., et al. Early effects of high-fat diet on neurovascular function and focal ischemic brain injury. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2013, 304:R1001-R1010.
199. Li Y., et al. Preconditioning with repeated hyperbaric oxygen induces myocardial and cerebral protection in patients undergoing coronary artery bypass graft surgery: a prospective, randomized, controlled clinical trial. J. Cardiothorac. Vasc. Anesth. 2011, 25:908-916.
200. Li Y., et al. Failure of normobaric oxygen therapy to reduce ischemic brain damage in rats. Undersea Hyperb. Med. 1994, 21:245-249.
201. Li Y.S., et al. Neuroprotection by inhaled nitric oxide in a murine stroke model is concentration and duration dependent. Brain Res. 2013, 1507:134-145.
202. Li Z., et al. Protective effects of exogenous hydrogen sulfide on neurons of hippocampus in a rat model of brain ischemia. Neurochem. Res. 2011, 36:1840-1849.
203. Lim S.W., et al. Microglial activation induced by traumatic brain injury is suppressed by postinjury treatment with hyperbaric oxygen therapy. J. Surg. Res. 2013.
204. Lin J.W., et al. Effect of hyperbaric oxygen on patients with traumatic brain injury. Acta Neurochir. Suppl. 2008, 101:145-149.
205. Lin K.C., et al. Attenuating inflammation but stimulating both angiogenesis and neurogenesis using hyperbaric oxygen in rats with traumatic brain injury. J. Trauma Acute Care Surg. 2012, 72:650-659.
206. Liu H.G., et al. Effect of Sevoflurane postconditioning on gene expression in brain tissue of the middle cerebral artery occlusion rat model. Mol. Biol. Rep. 2012, 39:10505-10510.
207. Liu S., et al. Electron paramagnetic resonance-guided normobaric hyperoxia treatment protects the brain by maintaining penumbral oxygenation in a rat model of transient focal cerebral ischemia. J. Cereb. Blood Flow Metab. 2006, 26:1274-1284.
208. Liu W., et al. Normobaric hyperoxia protects the blood brain barrier through inhibiting Nox2 containing NADPH oxidase in ischemic stroke. Med. Gas Res. 2011, 1:22.
209. Liu W., et al. Normobaric hyperoxia reduces the neurovascular complications associated with delayed tissue plasminogen activator treatment in a rat model of focal cerebral ischemia. Stroke 2009, 40:2526-2531.
210. Liu W., et al. Normobaric hyperoxia attenuates early blood-brain barrier disruption by inhibiting MMP-9-mediated occludin degradation in focal cerebral ischemia. J. Neurochem. 2009, 108:811-820.
211. Liu X.H., et al. Hyperbaric oxygenation reduces long-term brain injury and ameliorates behavioral function by suppression of apoptosis in a rat model of neonatal hypoxia-ischemia. Neurochem. Int. 2013, 62:922-930.
212. Liu Y., et al. Helium preconditioning attenuates hypoxia/ischemia-induced injury in the developing brain. Brain Res. 2011, 1376:122-129.
213. Liu Z., et al. Effect of hyperbaric oxygen on cytochrome C. Bcl-2 and Bax expression after experimental traumatic brain injury in rats. Chin. J. Traumatol. 2006, 9:168-174.
214. Lo C.P., et al. Brain injury after acute carbon monoxide poisoning: early and late complications. Am. J. Roentgenol. 2007, 189:W205-W210.
215. Lockwood G. Expansion of air bubbles in aqueous solutions of nitrous oxide or xenon. Br. J. Anaesth. 2002, 89:282-286.
216. Lockwood G.G., et al. Feasibility and safety of delivering xenon to patients undergoing coronary artery bypass graft surgery while on cardiopulmonary bypass - phase I study. Anesthesiology 2006, 104:458-465.
217. Loetscher P.D., et al. Argon: neuroprotection in in vitro models of cerebral ischemia and traumatic brain injury. Crit. Care 2009, 13:R206.
218. Lopez A.D., et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006, 367:1747-1757.
219. Lorenz I.H., et al. Subanesthetic concentration of sevoflurane increases regional cerebral blood flow more, but regional cerebral blood volume less, than subanesthetic concentration of isoflurane in human volunteers. J. Neurosurg. Anesthesiol. 2001, 13:288-295.
220. Lu M., et al. Hydrogen sulfide regulates intracellular pH in rat primary cultured glia cells. Neurosci. Res. 2010, 66:92-98.
221. Lu P.G., et al. Functional recovery in rat spinal cord injury induced by hyperbaric oxygen preconditioning. Neurol. Res. 2012, 34:944-951.
222. Luh C., et al. Influence of a brief episode of anesthesia during the induction of experimental brain trauma on secondary brain damage and inflammation. PLoS ONE 2011, 6:e19948.
223. Lundborg C., et al. Ifenprodil restores GDNF-evoked Ca(2+) signalling and Na(+)/K(+)-ATPase expression in inflammation-pretreated astrocytes. J. Neurochem. 2011, 119:686-696.
224. Luo Y., et al. Xenon and sevoflurane protect against brain injury in a neonatal asphyxia model. Anesthesiology 2008, 109:782-789.
225. Ma D., et al. Combination of xenon and isoflurane produces a synergistic protective effect against oxygen-glucose deprivation injury in a neuronal-glial co-culture model. Anesthesiology 2003, 99:748-751.
226. Ma D., et al. Xenon mitigates isoflurane-induced neuronal apoptosis in the developing rodent brain. Anesthesiology 2007, 106:746-753.
227. Magnoni S., et al. Lack of improvement in cerebral metabolism after hyperoxia in severe head injury: a microdialysis study. J. Neurosurg. 2003, 98:952-958.
228. Mahajan V.A., et al. Recovery of older patients undergoing ambulatory anaesthesia with isoflurane or sevoflurane. Eur. J. Anaesthesiol. 2007, 24:505-510.
229. Matchett G.A., et al. Hydrogen gas is ineffective in moderate and severe neonatal hypoxia-ischemia rat models. Brain Res. 2009, 1259:90-97.
230. Matchett G.A., et al. Hyperbaric oxygen therapy and cerebral ischemia: neuroprotective mechanisms. Neurol. Res. 2009, 31:114-121.
231. Matsunami T., et al. Antioxidant status and lipid peroxidation in diabetic rats under hyperbaric oxygen exposure. Physiol. Res./Acad. Sci. Bohemosl. 2010, 59:97-104.
232. McAuliffe J.J., et al. Isoflurane-delayed preconditioning reduces immediate mortality and improves striatal function in adult mice after neonatal hypoxia-ischemia. Anesth. Analg. 2007, 104:1066-1077. (tables of contents).
233. McAuliffe J.J., et al. Desflurane, isoflurane, and sevoflurane provide limited neuroprotection against neonatal hypoxia-ischemia in a delayed preconditioning paradigm. Anesthesiology 2009, 111:533-546.
234. McCormick M.T., et al. Management of hyperglycemia in acute stroke: how, when, and for whom?. Stroke 2008, 39:2177-2185.
235. Mennerick S., et al. Effect of nitrous oxide on excitatory and inhibitory synaptic transmission in hippocampal cultures. J. Neurosci. 1998, 18:9716-9726.
236. Michenfelder J.D., et al. Isoflurane when compared to enflurane and halothane decreases the frequency of cerebral ischemia during carotid endarterectomy. Anesthesiology 1987, 67:336-340.
237. Miyazaki H., et al. Increase of glutamate uptake in astrocytes: a possible mechanism of action of volatile anesthetics. Anesthesiology 1997, 86:1359-1366. (discussion 1358A).
238. Moe M.C., et al. Sevoflurane reduces synaptic glutamate release in human synaptosomes. J. Neurosurg. Anesthesiol. 2002, 14:180-186.
239. Mohammadi E., Bigdeli M.R. Effects of preconditioning with normobaric hyperoxia on Na(+)/Ca(2+) exchanger in the rat brain. Neuroscience 2013, 237:277-284.
240. Moss E., et al. Effects of 2% enflurane on intracranial pressure and cerebral perfusion pressure. Br. J. Anaesth. 1983, 55:1083-1088.
241. +-ATPase activities in global cerebral ischemia-exposed rats. Neurochem. Int. 2004, 44:585-594.
242. Mu J., et al. Delayed hyperbaric oxygen therapy induces cell proliferation through stabilization of cAMP responsive element binding protein in the rat model of MCAo-induced ischemic brain injury. Neurobiol. Dis. 2013, 51:133-143.
243. Mu J., et al. Subanesthetic dose of isoflurane protects against zymosan-induced generalized inflammation and its associated acute lung injury in mice. Shock 2010, 34:183-189.
244. Nagatomo F., et al. Effects of hyperbaric oxygenation on blood pressure levels of spontaneously hypertensive rats. Clin. Exp. Hypertens. 2010, 32:193-197.
245. Nakagawa Y., et al. Effects of hypercapnia on enhancement of decreased perfusion flow in non-infarcted brain tissues. Stroke 1981, 12:85-92.
246. Nakamura T., et al. Hyperbaric oxygen therapy for consciousness disturbance following head injury in subacute phase. Acta Neurochir. Suppl. 2008, 102:21-24.
247. Nasrniya S., Bigdeli M.R. Ischemic tolerance induced by normobaric hyperoxia and evaluation of group I and II metabotropic glutamate receptors. Curr. Neurovasc. Res. 2013, 10:21-28.
248. Neto J.S., et al. Protection of transplant-induced renal ischemia-reperfusion injury with carbon monoxide. Am. J. Physiol. Renal Physiol. 2004, 287:F979-F980.
249. Newberg L.A., Michenfelder J.D. Cerebral protection by isoflurane during hypoxemia or ischemia. Anesthesiology 1983, 59:29-35.
250. Newberg L.A., et al. The cerebral metabolic effects of isoflurane at and above concentrations that suppress cortical electrical activity. Anesthesiology 1983, 59:23-28.
251. Nie H., et al. Effects of sevoflurane on self-renewal capacity and differentiation of cultured neural stem cells. Neurochem. Res. 2013, 38:1758-1767.
252. Nie H., et al. Hyperbaric oxygen preconditioning induces tolerance against spinal cord ischemia by upregulation of antioxidant enzymes in rabbits. J. Cereb. Blood Flow Metab. 2006, 26:666-674.
253. Nortje J., et al. Effect of hyperoxia on regional oxygenation and metabolism after severe traumatic brain injury: preliminary findings. Crit. Care Med. 2008, 36:273-281.
254. Ohsawa I., et al. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat. Med. 2007, 13:688-694.
255. 2 level. Med. Gas Res. 2012, 2:21.
256. Ostrowski R.P., et al. The hyperbaric oxygen preconditioning-induced brain protection is mediated by a reduction of early apoptosis after transient global cerebral ischemia. Neurobiol. Dis. 2008, 29:1-13.
257. Ostrowski R.P., et al. Hyperbaric oxygen suppresses NADPH oxidase in a rat subarachnoid hemorrhage model. Stroke 2006, 37:1314-1318.
258. Ozkul A., et al. The effect of insulin resistance on inflammatory response and oxidative stress in acute cerebral ischemia. Neuroendocrinol. Lett. 2013, 34:52-57.
259. Padma M.V., et al. Normobaric oxygen therapy in acute ischemic stroke: a pilot study in Indian patients. Ann. Indian Acad. Neurol. 2010, 13:284-288.
260. Palmer R.M., et al. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987, 327:524-526.
261. Pan Y., et al. The effect of heliox treatment in a rat model of focal transient cerebral ischemia. Neurosci. Lett. 2011, 497:144-147.
262. Pan Y., et al. Heliox and oxygen reduce infarct volume in a rat model of focal ischemia. Exp. Neurol. 2007, 205:587-590.
263. Pang L., et al. Elevated serum ubiquitin C-terminal hydrolase-L1 levels in patients with carbon monoxide poisoning. Clin. Biochem. 2013.
264. Parfenova H., et al. Cerebral vascular endothelial heme oxygenase: expression, localization, and activation by glutamate. Am. J. Physiol. Cell Physiol. 2001, 281:C1954-C1960.
265. Pasternak J.J., et al. Effect of nitrous oxide use on long-term neurologic and neuropsychological outcome in patients who received temporary proximal artery occlusion during cerebral aneurysm clipping surgery. Anesthesiology 2009, 110:563-573.
266. + channels. Nat. Neurosci. 1999, 2:422-426.
267. Payne R.S., et al. Sevoflurane-induced preconditioning protects against cerebral ischemic neuronal damage in rats. Brain Res. 2005, 1034:147-152.
268. Peng S., et al. Sevoflurane postconditioning ameliorates oxygen-glucose deprivation-reperfusion injury in the rat hippocampus. CNS Neurosci. Ther. 2011, 17:605-611.
269. Petzelt C., et al. Prevention of neurotoxicity in hypoxic cortical neurons by the noble gas xenon. Life Sci. 2003, 72:1909-1918.
270. Pham H., et al. Inhaled NO protects cerebral white matter in neonatal rats with combined brain and lung injury. Am. J. Respir. Crit. Care Med. 2012, 185:897-899.
271. Piehl E., et al. The effect of sevoflurane on neuronal degeneration and GABAA subunit composition in a developing rat model of organotypic hippocampal slice cultures. J. Neurosurg. Anesthesiol. 2010, 22:220-229.
272. Prockop L.D., Chichkova R.I. Carbon monoxide intoxication: an updated review. J. Neurol. Sci. 2007, 262:122-130.
273. Qin Z., et al. Hyperbaric oxygen-induced attenuation of hemorrhagic transformation after experimental focal transient cerebral ischemia. Stroke 2007, 38:1362-1367.
274. Qu K., et al. Hydrogen sulfide is a mediator of cerebral ischemic damage. Stroke 2006, 37:889-893.
275. Qu K., et al. Hydrogen sulfide: neurochemistry and neurobiology. Neurochem. Int. 2008, 52:155-165.
276. Rasmussen L.S., et al. Comparison of xenon with propofol for supplementary general anaesthesia for knee replacement: a randomized study. Br. J. Anaesth. 2006, 97:154-159.
277. Reiffenstein R.J., et al. Toxicology of hydrogen sulfide. Annu. Rev. Pharmacol. Toxicol. 1992, 32:109-134.
278. Ren C., et al. Dynamic change of hydrogen sulfide during global cerebral ischemia-reperfusion and its effect in rats. Brain Res. 2010, 1345:197-205.
279. Riess M.L., et al. Attenuation of mitochondrial respiration by sevoflurane in isolated cardiac mitochondria is mediated in part by reactive oxygen species. Anesthesiology 2004, 100:498-505.
280. Ristow M. Neurodegenerative disorders associated with diabetes mellitus. J. Mol. Med. (Berl.) 2004, 82:510-529.
281. Rockswold G.L., et al. Results of a prospective randomized trial for treatment of severely brain-injured patients with hyperbaric oxygen. J. Neurosurg. 1992, 76:929-934.
282. Rockswold S.B., et al. Effects of hyperbaric oxygenation therapy on cerebral metabolism and intracranial pressure in severely brain injured patients. J. Neurosurg. 2001, 94:403-411.
283. Rockswold S.B., et al. A prospective, randomized Phase II clinical trial to evaluate the effect of combined hyperbaric and normobaric hyperoxia on cerebral metabolism, intracranial pressure, oxygen toxicity, and clinical outcome in severe traumatic brain injury. J. Neurosurg. 2013, 118:1317-1328.
284. Rockswold S.B., et al. A prospective, randomized clinical trial to compare the effect of hyperbaric to normobaric hyperoxia on cerebral metabolism, intracranial pressure, and oxygen toxicity in severe traumatic brain injury. J. Neurosurg. 2010, 112:1080-1094.
285. Rogatsky G.G., et al. Optimal dosing as a necessary condition for the efficacy of hyperbaric oxygen therapy in acute ischemic stroke: a critical review. Neurol. Res. 2003, 25:95-98.
286. Roger V.L., et al. Heart disease and stroke statistics - update: a report from the American Heart Association. Circulation 2011, 123:e18-e209.
287. Rortgen D., et al. Comparison of early cognitive function and recovery after desflurane or sevoflurane anaesthesia in the elderly: a double-blinded randomized controlled trial. Br. J. Anaesth. 2010, 104:167-174.
288. Royse C.F., et al. The influence of propofol or desflurane on postoperative cognitive dysfunction in patients undergoing coronary artery bypass surgery. Anaesthesia 2011, 66:455-464.
289. Ryang Y.M., et al. Neuroprotective effects of argon in an in vivo model of transient middle cerebral artery occlusion in rats. Crit. Care Med. 2011, 39:1448-1453.
290. Sahni T., et al. Use of hyperbaric oxygen in traumatic brain injury: retrospective analysis of data of 20 patients treated at a tertiary care centre. Br. J. Neurosurg. 2012, 26:202-207.
291. Sakai H., et al. Isoflurane provides long-term protection against focal cerebral ischemia in the rat. Anesthesiology 2007, 106:92-99. (discussion 98-10).
292. Sammut I.A., et al. Carbon monoxide is a major contributor to the regulation of vascular tone in aortas expressing high levels of haeme oxygenase-1. Br. J. Pharmacol. 1998, 125:1437-1444.
293. Sanders R.D., et al. Argon neuroprotection. Crit. Care 2010, 14:117.
294. Sang H., et al. Isoflurane produces delayed preconditioning against spinal cord ischemic injury via release of free radicals in rabbits. Anesthesiology 2006, 105:953-960.
295. Sarwar N., et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010, 375:2215-2222.
296. Sasaoka N., et al. Isoflurane exerts a short-term but not a long-term preconditioning effect in neonatal rats exposed to a hypoxic-ischaemic neuronal injury. Acta Anaesthesiol. Scand. 2009, 53:46-54.
297. Schifilliti D., et al. Anaesthetic-related neuroprotection: intravenous or inhalational agents?. CNS Drugs 2010, 24:893-907.
298. Schmidt M., et al. Xenon attenuates cerebral damage after ischemia in pigs. Anesthesiology 2005, 102:929-936.
299. Schoen J., et al. Cognitive function after sevoflurane- vs propofol-based anaesthesia for on-pump cardiac surgery: a randomized controlled trial. Br. J. Anaesth. 2011, 106:840-850.
300. Schwer C.I., et al. Carbon monoxide releasing molecule-2 inhibits pancreatic stellate cell proliferation by activating p38 mitogen-activated protein kinase/heme oxygenase-1 signaling. Mol. Pharmacol. 2010, 77:660-669.
301. Seo J.H., et al. Combined treatment with celecoxib and sevoflurane after global cerebral ischaemia has no additive neuroprotective effects in rats. Br. J. Anaesth. 2013, 110:988-995.
302. Shen X., et al. Selective anesthesia-induced neuroinflammation in developing mouse brain and cognitive impairment. Anesthesiology 2013, 118:502-515.
303. Shi H., et al. miR-15b suppression of Bcl-2 contributes to cerebral ischemic injury and is reversed by sevoflurane preconditioning. CNS Neurol. Disord. Drug Targets 2013, 12:381-391.
304. Shin H.K., et al. Normobaric hyperoxia improves cerebral blood flow and oxygenation, and inhibits peri-infarct depolarizations in experimental focal ischaemia. Brain 2007, 130:1631-1642.
305. Shu Y., et al. Xenon pretreatment attenuates anesthetic-induced apoptosis in the developing brain in comparison with nitrous oxide and hypoxia. Anesthesiology 2010, 113:360-368.
306. Sigaut S., et al. The preconditioning effect of sevoflurane on the oxygen glucose-deprived hippocampal slice: the role of tyrosine kinases and duration of ischemia. Anesth. Analg. 2009, 108:601-608.
307. Sima A.A. Encephalopathies: the emerging diabetic complications. Acta Diabetol. 2010, 47:279-293.
308. Singhal A.B., et al. A pilot study of normobaric oxygen therapy in acute ischemic stroke. Stroke 2005, 36:797-802.
309. Singhal A.B., et al. Normobaric hyperoxia reduces MRI diffusion abnormalities and infarct size in experimental stroke. Neurology 2002, 58:945-952.
310. Singhal A.B., et al. Magnetic resonance spectroscopy study of oxygen therapy in ischemic stroke. Stroke 2007, 38:2851-2854.
311. Singhal A.B., et al. Effects of normobaric hyperoxia in a rat model of focal cerebral ischemia-reperfusion. J. Cereb. Blood Flow Metab. 2002, 22:861-868.
312. Smiley R.M. An overview of induction and emergence characteristics of desflurane in pediatric, adult, and geriatric patients. Anesth. Analg. 1992, 75:S38-S44. (discussion S44-S36).
313. Soejima Y., et al. Hyperbaric oxygen preconditioning attenuates hyperglycemia-enhanced hemorrhagic transformation by inhibiting matrix metalloproteinases in focal cerebral ischemia in rats. Exp. Neurol. 2013.
314. Soejima Y., et al. Hyperbaric oxygen preconditioning attenuates hyperglycemia enhanced hemorrhagic transformation after transient MCAO in rats. Med. Gas Res. 2012, 2:9.
315. Sponheim S., et al. Effects of 0.5 and 1.0 MAC isoflurane, sevoflurane and desflurane on intracranial and cerebral perfusion pressures in children. Acta Anaesthesiol. Scand. 2003, 47:932-938.
316. Statler K.D., et al. Isoflurane exerts neuroprotective actions at or near the time of severe traumatic brain injury. Brain Res. 2006, 1076:216-224.
317. Statler K.D., et al. Hyperglycolysis is exacerbated after traumatic brain injury with fentanyl vs. isoflurane anesthesia in rats. Brain Res. 2003, 994:37-43.
318. Statler K.D., et al. Isoflurane improves long-term neurologic outcome versus fentanyl after traumatic brain injury in rats. J. Neurotrauma 2000, 17:1179-1189.
319. Stowe D.F., Kevin L.G. Cardiac preconditioning by volatile anesthetic agents: a defining role for altered mitochondrial bioenergetics. Antioxid. Redox Signal. 2004, 6:439-448.
320. Strebel S., et al. Dynamic and static cerebral autoregulation during isoflurane, desflurane, and propofol anesthesia. Anesthesiology 1995, 83:66-76.
321. Sukhotnik I., et al. Effect of 100% oxygen on E-selectin expression, recruitment of neutrophils and enterocyte apoptosis following intestinal ischemia-reperfusion in a rat. Pediatr. Surg. Int. 2008, 24:29-35.
322. Sun B. Inhaled nitric oxide and neonatal brain damage: experimental and clinical evidences. J. Matern. Fetal Neonat. 2012, 25(Suppl 1):51-54.
323. Sun L., et al. Oxygen therapy improves energy metabolism in focal cerebral ischemia. Brain Res. 2011, 1415:103-108.
324. Sun Q., et al. Hydrogen-rich saline reduces delayed neurologic sequelae in experimental carbon monoxide toxicity. Crit. Care Med. 2011, 39:765-769.
325. Tanaka K., et al. Mitochondrial adenosine triphosphate-regulated potassium channel opening acts as a trigger for isoflurane-induced preconditioning by generating reactive oxygen species. Anesthesiology 2003, 98:935-943.
326. Tay A.S., et al. Hydrogen sulfide protects neurons against hypoxic injury via stimulation of ATP-sensitive potassium channel/protein kinase C/extracellular signal-regulated kinase/heat shock protein 90 pathway. Neuroscience 2010, 167:277-286.
327. Tenhunen R., et al. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc. Natl. Acad. Sci. U. S. A. 1968, 61:748-755.
328. Terpolilli N.A., et al. Inhalation of nitric oxide prevents ischemic brain damage in experimental stroke by selective dilatation of collateral arterioles. Circ. Res. 2012, 110:727-738.
329. Terpolilli N.A., et al. Inhaled nitric oxide reduces secondary brain damage after traumatic brain injury in mice. J. Cereb. Blood Flow Metab. 2013, 33:311-318.
330. Thom S.R., et al. Hyperbaric oxygen reduces delayed immune-mediated neuropathology in experimental carbon monoxide toxicity. Toxicol. Appl. Pharmacol. 2006, 213:152-159.
331. Thoresen M., et al. Cooling combined with immediate or delayed xenon inhalation provides equivalent long-term neuroprotection after neonatal hypoxia-ischemia. J. Cereb. Blood Flow Metab. 2009, 29:707-714.
332. Tian X., et al. Hyperbaric oxygen and Ginkgo Biloba extract inhibit Abeta25-35-induced toxicity and oxidative stress in vivo: a potential role in Alzheimer's disease. Int. J. Neurosci. 2012, 122:563-569.
333. Tian X., et al. The protective effect of hyperbaric oxygen and Ginkgo biloba extract on Abeta25-35-induced oxidative stress and neuronal apoptosis in rats. Behav. Brain Res. 2013, 242:1-8.
334. Tibbles P.M., Edelsberg J.S. Hyperbaric-oxygen therapy. N. Engl. J. Med. 1996, 334:1642-1648.
335. Tolias C.M., et al. Normobaric hyperoxia-induced improvement in cerebral metabolism and reduction in intracranial pressure in patients with severe head injury: a prospective historical cohort-matched study. J. Neurosurg. 2004, 101:435-444.
336. Toner C.C., et al. Effects of sevoflurane on dopamine, glutamate and aspartate release in an in vitro model of cerebral ischaemia. Br. J. Anaesth. 2001, 86:550-554.
337. van Laerhoven H., et al. Prognostic tests in term neonates with hypoxic-ischemic encephalopathy: a systematic review. Pediatrics 2013, 131:88-98.
338. Van Trigt P., et al. The mechanism of halothane-induced myocardial depression. Altered diastolic mechanics versus impaired contractility. J. Thorac. Cardiovasc. Surg. 1983, 85:832-838.
339. Vannucci R.C., et al. Effect of carbon dioxide on cerebral metabolism during hypoxia-ischemia in the immature rat. Pediatr. Res. 1997, 42:24-29.
340. Vannucci R.C., et al. Effect of extreme hypercapnia on hypoxic-ischemic brain damage in the immature rat. Pediatr. Res. 2001, 49:799-803.
341. Vannucci R.C., et al. Carbon dioxide protects the perinatal brain from hypoxic-ischemic damage: an experimental study in the immature rat. Pediatrics 1995, 95:868-874.
342. Vavilala M.S., et al. The influence of inhaled nitric oxide on cerebral blood flow and metabolism in a child with traumatic brain injury. Anesth. Analg. 2001, 93:351-353. (353rd contents page).
343. Velly L.J., et al. Early anesthetic preconditioning in mixed cortical neuronal-glial cell cultures subjected to oxygen-glucose deprivation: the role of adenosine triphosphate dependent potassium channels and reactive oxygen species in sevoflurane-induced neuroprotection. Anesth. Analg. 2009, 108:955-963.
344. Veltkamp R., et al. Hyperbaric oxygen reduces basal lamina degradation after transient focal cerebral ischemia in rats. Brain Res. 2006, 1076:231-237.
345. Veltkamp R., et al. Hyperbaric oxygen reduces blood-brain barrier damage and edema after transient focal cerebral ischemia. Stroke 2005, 36:1679-1683.
346. Veltkamp R., et al. Oxygen therapy in permanent brain ischemia: potential and limitations. Brain Res. 2006, 1107:185-191.
347. Vilalta A., et al. Normobaric hyperoxia in traumatic brain injury: does brain metabolic state influence the response to hyperoxic challenge?. J. Neurotrauma 2011, 28:1139-1148.
348. Villa F., et al. Inhalation versus endovenous sedation in subarachnoid hemorrhage patients: effects on regional cerebral blood flow. Crit. Care Med. 2012, 40:2797-2804.
349. Vlodavsky E., et al. Hyperbaric oxygen therapy reduces neuroinflammation and expression of matrix metalloproteinase-9 in the rat model of traumatic brain injury. Neuropathol. Appl. Neurobiol. 2006, 32:40-50.
350. Wang B., et al. Carbon monoxide-activated Nrf2 pathway leads to protection against permanent focal cerebral ischemia. Stroke 2011, 42:2605-2610.
351. Wang C., et al. Pretreatment with volatile anesthetics, but not with the nonimmobilizer 1,2-dichlorohexafluorocyclobutane, reduced cell injury in rat cerebellar slices after an in vitro simulated ischemia. Brain Res. 2007, 1152:201-208.
352. Wang G.H., et al. Neuroprotective effects of hyperbaric oxygen treatment on traumatic brain injury in the rat. J. Neurotrauma 2010, 27:1733-1743.
353. Wang H., et al. Sevoflurane preconditioning confers neuroprotection via anti-inflammatory effects. Front. Biosci. (Elite Ed.) 2011, 3:604-615.
354. Wang J.K., et al. Postconditioning with sevoflurane protects against focal cerebral ischemia and reperfusion injury via PI3K/Akt pathway. Brain Res. 2010, 1357:142-151.
355. Wang L., et al. Inhalational anesthetics as preconditioning agents in ischemic brain. Curr. Opin. Pharmacol. 2008, 8:104-110.
356. Wang P., et al. MRI findings of otic and sinus barotrauma in patients with carbon monoxide poisoning during hyperbaric oxygen therapy. PLoS ONE 2013, 8:e65672.
357. Wang S., et al. Duplicate preconditioning with sevoflurane in vitro improves neuroprotection in rat brain via activating the extracellular signal-regulated protein kinase. Neurosci. Bull. 2010, 26:437-444.
358. Wang W., et al. Effects of hydrogen-rich saline on rats with acute carbon monoxide poisoning. J. Emerg. Med. 2013, 44:107-115.
359. Wang X.L., et al. Proliferation of neural stem cells correlates with Wnt-3 protein in hypoxic-ischemic neonate rats after hyperbaric oxygen therapy. Neuroreport 2007, 18:1753-1756.
360. Wang X.L., et al. Therapeutic window of hyperbaric oxygen therapy for hypoxic-ischemic brain damage in newborn rats. Brain Res. 2008, 1222:87-94.
361. Wang Y., et al. Chronic exposure of gestation rat to sevoflurane impairs offspring brain development. Neurol. Sci.: Off. J. Ital. Neurol. Soc. Ital. Soc. Clin. Neurophysiol. 2012, 33:535-544.
362. Wang Z.P., et al. Protective effect of sevoflurane preconditioning on oxygen-glucose deprivation injury in rat hippocampal slices: the role of mitochondrial K(ATP) channels. Sheng Li Xue Bao 2006, 58:201-206.
363. Weaver L.K., et al. Hyperbaric oxygen for acute carbon monoxide poisoning. N. Engl. J. Med. 2002, 347:1057-1067.
364. Weber N.C., et al. Xenon preconditioning differently regulates p44/42 MAPK (ERK 1/2) and p46/54 MAPK (JNK 1/2 and 3) in vivo. Br. J. Anaesth. 2006, 97:298-306.
365. Weber N.C., et al. Upstream signaling of protein kinase C-epsilon in xenon-induced pharmacological preconditioning. Implication of mitochondrial adenosine triphosphate dependent potassium channels and phosphatidylinositol-dependent kinase-1. Eur. J. Pharmacol. 2006, 539:1-9.
366. Weber N.C., et al. The noble gas xenon induces pharmacological preconditioning in the rat heart in vivo via induction of PKC-epsilon and p38 MAPK. Br. J. Pharmacol. 2005, 144:123-132.
367. Wei X.E., et al. Quantitative evaluation of hyperbaric oxygen efficacy in experimental traumatic brain injury: an MRI study. Neurol. Sci. 2013.
368. Wells B.A., et al. Increased tolerance to cerebral ischemia produced by general anesthesia during temporary carotid occlusion. Surgery 1963, 54:216-223.
369. Weng Y., Sun S. Therapeutic hypothermia after cardiac arrest in adults: mechanism of neuroprotection, phases of hypothermia, and methods of cooling. Crit. Care Clin. 2012, 28:231-243.
370. Wilhelm S., et al. Effects of xenon on in vitro and in vivo models of neuronal injury. Anesthesiology 2002, 96:1485-1491.
371. Wise-Faberowski L., Osorio-Lujan S. Acute and sustained isoflurane neuroprotection: The effect of culture age and duration of oxygen and glucose deprivation. Brain Inj. 2013, 27:444-453.
372. Wise-Faberowski L., et al. Oxygen and glucose deprivation-induced neuronal apoptosis is attenuated by halothane and isoflurane. Anesth. Analg. 2001, 93:1281-1287.
373. Wise-Faberowski L., et al. Desflurane and sevoflurane attenuate oxygen and glucose deprivation-induced neuronal cell death. J. Neurosurg. Anesthesiol. 2003, 15:193-199.
374. Wolf E.G., et al. Hyperbaric side effects in a traumatic brain injury randomized clinical trial. Undersea Hyperb. Med. 2012, 39:1075-1082.
375. Wu O., et al. Evaluating effects of normobaric oxygen therapy in acute stroke with MRI-based predictive models. Med. Gas Res. 2012, 2:5.
376. Wu X., et al. The inhalation anesthetic isoflurane increases levels of proinflammatory TNF-alpha, IL-6, and IL-1beta. Neurobiol. Aging 2012, 33:1364-1378.
377. Xiong L., et al. Preconditioning with isoflurane produces dose-dependent neuroprotection via activation of adenosine triphosphate-regulated potassium channels after focal cerebral ischemia in rats. Anesth. Analg. 2003, 96:233-237.
378. Xiong L., et al. Hyperbaric oxygen preconditioning induces neuroprotection against ischemia in transient not permanent middle cerebral artery occlusion rat model. Chin. Med. J. (Engl.) 2000, 113:836-839.
379. Yamada K., et al. Protective role of ATP-sensitive potassium channels in hypoxia-induced generalized seizure. Science 2001, 292:1543-1546.
380. Yamakura T., et al. Subunit-dependent inhibition of human neuronal nicotinic acetylcholine receptors and other ligand-gated ion channels by dissociative anesthetics ketamine and dizocilpine. Anesthesiology 2000, 92:1144-1153.
381. Yamamoto Y., et al. Effects of xenon on ischemic spinal cord injury in rabbits: a comparison with propofol. Acta Anaesthesiol. Scand. 2010, 54:337-342.
382. Yamashita S., et al. Repeated preconditioning with hyperbaric oxygen induces neuroprotection against forebrain ischemia via suppression of p38 mitogen activated protein kinase. Brain Res. 2009, 1301:171-179.
383. Yan W., et al. SirT1 mediates hyperbaric oxygen preconditioning-induced ischemic tolerance in rat brain. J. Cereb. Blood Flow Metab. 2013, 33:396-406.
384. Yang Q., et al. Sevoflurane preconditioning induces neuroprotection through reactive oxygen species-mediated up-regulation of antioxidant enzymes in rats. Anesth. Analg. 2011, 112:931-937.
385. Yang Q., et al. Activation of canonical notch signaling pathway is involved in the ischemic tolerance induced by sevoflurane preconditioning in mice. Anesthesiology 2012, 117:996-1005.
386. Yang T., et al. Xenon and sevoflurane provide analgesia during labor and fetal brain protection in a perinatal rat model of hypoxia-ischemia. PLoS ONE 2012, 7:e37020.
387. Yang Y.J., et al. Hyperbaric oxygen induces endogenous neural stem cells to proliferate and differentiate in hypoxic-ischemic brain damage in neonatal rats. Undersea Hyperb. Med. 2008, 35:113-129.
388. Yang Z.J., et al. Hyperbaric oxygenation alleviates MCAO-induced brain injury and reduces hydroxyl radical formation and glutamate release. Eur. J. Appl. Physiol. 2010, 108:513-522.
389. Yao H., et al. The Kv2.1 channels mediate neuronal apoptosis induced by excitotoxicity. J. Neurochem. 2009, 108:909-919.
390. Ye R., et al. Sevoflurane preconditioning improves mitochondrial function and long-term neurologic sequelae after transient cerebral ischemia: role of mitochondrial permeability transition. Crit. Care Med. 2012, 40:2685-2693.
391. Ye Z., et al. Sevoflurane preconditioning induced delayed neuroprotection against focal cerebral ischemia in rats. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2009, 34:152-157.
392. Ye Z., et al. Delayed neuroprotection induced by sevoflurane via opening mitochondrial ATP-sensitive potassium channels and p38 MAPK phosphorylation. Neurol. Sci. 2012, 33:239-249.
393. Ye Z., et al. Sevoflurane postconditioning involves an up-regulation of HIF-1alpha and HO-1 expression via PI3K/Akt pathway in a rat model of focal cerebral ischemia. Brain Res. 2012, 1463:63-74.
394. Ye Z., et al. Sevoflurane-induced delayed neuroprotection involves mitoK(ATP) channel opening and PKC epsilon activation. Mol. Biol. Rep. 2012, 39:5049-5057.
395. Yin X., et al. Effect of hyperbaric oxygen on neurological recovery of neonatal rats following hypoxic-ischemic brain damage and its underlying mechanism. Int. J. Clin. Exp. Pathol. 2013, 6:66-75.
396. Yonamine R., et al. Coadministration of hydrogen gas as part of the carrier gas mixture suppresses neuronal apoptosis and subsequent behavioral deficits caused by neonatal exposure to sevoflurane in mice. Anesthesiology 2013, 118:105-113.
397. Young A.R., et al. Neuroprotection and stroke: time for a compromise. J. Neurochem. 2007, 103:1302-1309.
398. Yurdakoc A., et al. Effects of halothane, isoflurane, and sevoflurane on lipid peroxidation following experimental closed head trauma in rats. Acta Anaesthesiol. Scand. 2008, 52:658-663.
399. Zeynalov E., Dore S. Low doses of carbon monoxide protect against experimental focal brain ischemia. Neurotox. Res. 2009, 15:133-137.
400. Zhan Y., et al. Hydrogen gas ameliorates oxidative stress in early brain injury after subarachnoid hemorrhage in rats. Crit. Care Med. 2012, 40:1291-1296.
401. Zhang B., et al. Desflurane affords greater protection than halothane in the function of mitochondria against forebrain ischemia reperfusion injury in rats. Anesthesia and analgesia 2008, 106:1242-1249.
402. Zhang H.J., et al. Neuroprotection of sevoflurane against the ischemia injury in hippocampal slices of rat. Zhongguo Ying Yong Sheng Li Xue Za Zhi=Zhongguo Yingyong Shenglixue Zazhi=Chinese Journal of Applied Physiology 2008, 24:426-429.
403. Zhang H.P., et al. Isoflurane preconditioning induces neuroprotection by attenuating ubiquitin-conjugated protein aggregation in a mouse model of transient global cerebral ischemia. Anesth. Analg. 2010, 111:506-514.
404. Zhang H.P. The neuroprotective effects of isoflurane preconditioning in a murine transient global cerebral ischemia-reperfusion model: the role of the notch signaling pathway. Neuromol. Med. 2013, (Epub ahead of print).
405. Zhang J., et al. Isoflurane inhibits cyclic adenosine monophosphate response element-binding protein phosphorylation and calmodulin translocation to the nucleus of SH-SY5Y cells. Anesth. Analg. 2009, 109:1127-1134.
406. Zhang J.H., et al. Mechanisms of hyperbaric oxygen and neuroprotection in stroke. Pathophysiology 2005, 12:63-77.
407. Zhang S.D., et al. Protective effect of isoflurane and sevoflurane on ischemic neurons and expression of Bcl-2 and ICE genes in rat brain. Biomed. Environ. Sci. 2006, 19:143-146.
408. Zhang X., et al. Preconditioning with prolonged oxygen exposure induces ischemic tolerance in the brain via oxygen free radical formation. Can. J. Anaesth. 2004, 51:258-263.
409. Zhang X., et al. Subclinical concentration of sevoflurane potentiates neuronal apoptosis in the developing C57BL/6 mouse brain. Neurosci. Lett. 2008, 447:109-114.
410. Zhao P., et al. Isoflurane preconditioning improves long-term neurologic outcome after hypoxic-ischemic brain injury in neonatal rats. Anesthesiology 2007, 107:963-970.
411. Zhao P., Zuo Z. Isoflurane preconditioning induces neuroprotection that is inducible nitric oxide synthase-dependent in neonatal rats. Anesthesiology 2004, 101:695-703.
412. Zheng S., Zuo Z. Isoflurane preconditioning induces neuroprotection against ischemia via activation of P38 mitogen-activated protein kinases. Mol. Pharmacol. 2004, 65:1172-1180.
413. Zhou C., et al. HBO suppresses Nogo-A, Ng-R, or RhoA expression in the cerebral cortex after global ischemia. Biochem. Biophys. Res. Commun. 2003, 309:368-376.
414. Zhou H., et al. Protective effect of FTY720 against sevoflurane-induced developmental neurotoxicity in rats. Cell Biochem. Biophys. 2013.
415. Zhou J.G., et al. Effect of hyperbaric oxygen on the expression of nitric oxide synthase mRNA in cortex after acute traumatic cerebral injury. Zhongguo Ying Yong Sheng Li Xue Za Zhi 2012, 28:38-41.
416. Zhou Q., et al. Effects of permissive hypercapnia on transient global cerebral ischemia-reperfusion injury in rats. Anesthesiology 2010, 112:288-297.
417. Zhou X., et al. Neonatal exposure to sevoflurane causes apoptosis and reduces nNOS protein expression in rat hippocampus. Mol. Med. Reports 2012, 6:543-546.
418. Zhou Y., et al. Isoflurane posttreatment reduces neonatal hypoxic-ischemic brain injury in rats by the sphingosine-1-phosphate/phosphatidylinositol-3-kinase/Akt pathway. Stroke 2010, 41:1521-1527.
419. Zhou Z., et al. Carbon monoxide suppresses bleomycin-induced lung fibrosis. Am. J. Pathol. 2005, 166:27-37.
420. Zhu W., et al. Isoflurane preconditioning neuroprotection in experimental focal stroke is androgen-dependent in male mice. Neuroscience 2010, 169:758-769.
421. Zhuang L., et al. The protective profile of argon, helium, and xenon in a model of neonatal asphyxia in rats. Crit. Care Med. 2012, 40:1724-1730.
422. Zitta K., et al. Cytoprotective effects of the volatile anesthetic sevoflurane are highly dependent on timing and duration of sevoflurane conditioning: findings from a human, in-vitro hypoxia model. Eur. J. Pharmacol. 2010, 645:39-46.
423. Zuo Z., et al. Isoflurane preconditioning protects human neuroblastoma SH-SY5Y cells against in vitro simulated ischemia-reperfusion through the activation of extracellular signal-regulated kinases pathway. Eur. J. Pharmacol. 2006, 542:84-91.